Delivery Order SPE2DB20D2104-SPE2DB24FR49G

Award Date 12/6/23
Potential Completion Date 12/7/23
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Eucrisa 2% ointment. The contract has a ceiling value of $5,787.65 and a completion date of November 29, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $4,305.06, is for the supply of Eucrisa 2% Ointment 60 GM to DLA facilities in support of the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,026.84, is for the delivery of EUCRISA 2% Ointment 60GM, a prescription medication. The contract has a performance period through June 4, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award is for the delivery of Eucrisa 2% ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,384.68 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $7,963.75, and an ultimate completion date of July 26, 2024. The award covers the procurement of EUCRISA 2% Ointment 60GM, a pharmaceutical product, to support federal healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,343.33 delivery order contract is for the provision of EUCRISA 2% ointment 100GM, a prescription medication. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025,...
This federal contract award is a delivery order with a firm fixed price of $1,443.41 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUCRISA 2% Ointment 60GM, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,458.23 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a topical medication, to support military healthcare programs. The award is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award (SPE2DB20D3505|SPE2DB24FT5B9) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,939.73 firm fixed-price delivery order is for the pharmaceutical product EUCRISA 2% Ointment 60GM. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023 with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of EUCRISA 2% ointment, a specialty pharmaceutical product, with a ceiling value of $1,554.51 and an ultimate completion date of January 14, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition....
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FR49G
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,991.09 contract is for the delivery of Eucrisa 2% ointment, a prescription skin treatment medication, with a completion date of December 7, 2023.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies.

The contract award is not designated with a set-aside requirement, indicating open competition. As a major distributor of pharmaceutical and medical products to federal agencies, Amerisourcebergen plays a critical role in supplying these essential materials to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/27/25, 11:30 AM